The effect of monochromatic infrared energy therapy on diabetic feet with peripheral sensory Neuropathy - a randomized controlled trial

INTRODUCTION: Peripheral diabetic neuropathy has been a burden to the health and economy with increasing number of the morbidity and mortality following foot ulcer and amputation . Being an irreversible disease, foot care and glycemic control is the mainstay of treatment. Various adjunct treatmen...

Full description

Bibliographic Details
Main Author: Sadagatullah, Abdul Nawfar
Format: Article
Language:English
Published: Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia 2010
Subjects:
Online Access:http://eprints.usm.my/53543/1/Dr%20Abdul%20Nawfar%20Bin%20Sadagatullah-Eprints.pdf
Description
Summary:INTRODUCTION: Peripheral diabetic neuropathy has been a burden to the health and economy with increasing number of the morbidity and mortality following foot ulcer and amputation . Being an irreversible disease, foot care and glycemic control is the mainstay of treatment. Various adjunct treatments to improve neuropathy had been introduced to the market. Among them was Monochromatic Infrared Energy Therapy (MIRE) which was claims to produce promising results. This study focused on the effect of MIRE on the diabetic foot peripheral neuropathy. The main difference compared to other studies done before was the use of a neurometer for neuropathy assessment which is more quantitative and sensitive . OBJECTIVE: To assess the effect of MIRE on diabetic feet associated with peripheral neuropathy METHODOLOGY: A randomized controlled single blinded study was conducted at Hospital Sains Malaysia from February to October 2008. A total of 30 lower limbs from 24 patients were enrolled into the study. The neuropathy was screened by Michigan Neuropathy Scoring Investigation (MNSI) followed by the assessment of the Current Perception Threshold using a neurometer at 2000Hz, 250Hz and 5Hz frequencies. The limbs were randomized to receive either daily MIRE or placebo treatment for a total of 12 treatments. The foot was reassessed again with neurometer within a week of completion of the treatment and at 6 weeks following treatment RESULTS: The data obtained was analyzed with non parametric test to compare between the pre-treatment and post treatment groups. The inter relationship of each result between these 2 groups was confirmed by Chi-Square test. We found that there was no significant difference (p>0.05) between the neuropathic foot of diabetic patient in both MIRE and placebo groups . CONCLUSION: There was no improvement of neuropathy in the diabetic foot patient following MIRE treatment.